Implantable fluid management system for treating heart failure
A device and methods for treating renal failure are disclosed. One embodiment of the device is an implantable peritoneal dialysis device. When in use, the device can have a semi-permeable reservoir implanted in the peritoneal cavity. The reservoir can receive blood waste and drain through one or more conduits, via a pump, to the biological bladder. Solids and/or a solution benefiting dialysis can be pumped to the reservoir and/or implanted in the peritoneal cavity.
1. A method of treating congestive heart failure of a subject in need thereof and having a peritoneal cavity and a bladder, the method comprising:
introducing an infusate comprising an osmotic agent into the peritoneal cavity from a reservoir to form a peritoneal fluid mixture, the reservoir connected to an implantable pump by a reservoir conduit; and
pumping, using the implantable pump comprising a gear-pump and a controller, the peritoneal fluid mixture from the peritoneal cavity into the bladder responsive to control of the gear-pump by the controller,
wherein the peritoneal fluid mixture comprises the infusate comprising the osmotic agent, and
wherein the method treats the congestive heart failure of the subject.
2. The method of claim 1 , further comprising monitoring a physiologic parameter, and
wherein introducing the infusate comprises pumping, using the implantable pump, the infusate from the reservoir to the peritoneal cavity responsive to a value of the monitored physiologic parameter.
3. The method of claim 1 , further comprising monitoring a physiologic parameter, and
wherein pumping the peritoneal fluid mixture comprises pumping the peritoneal fluid mixture from the peritoneal cavity to the bladder responsive to a value of the monitored physiologic parameter.
4. The method of claim 1 , further comprising implanting the reservoir.
5. The method of claim 1 , wherein introducing the infusate comprises introducing the infusate into the peritoneal cavity from the reservoir through the reservoir conduit.
6. The method of claim 1 , wherein pumping the peritoneal fluid mixture comprises pumping the peritoneal fluid mixture from the peritoneal cavity through a drainage conduit into the bladder through an exit conduit,
wherein the drainage conduit is adapted for coupling between the peritoneal cavity and the implantable pump and the exit conduit is adapted for coupling between the implantable pump and the bladder.
7. The method of claim 1 , wherein introducing the infusate comprises pumping, using the implantable pump, the infusate into the peritoneal cavity from the reservoir as a function of time.
8. The method of claim 1 , wherein pumping the peritoneal fluid mixture comprises pumping the peritoneal fluid mixture from the peritoneal cavity to the bladder as a function of time.
9. The method of claim 1 , wherein pumping the peritoneal fluid mixture from the peritoneal cavity into the bladder occurs after a time-delay.
10. The method of claim 1 , wherein pumping the peritoneal fluid mixture comprises pumping the peritoneal fluid mixture at a set flow rate.
11. A method of treating congestive heart failure of a subject in need thereof and having a peritoneal cavity and a bladder, the method comprising:
introducing an infusate comprising an osmotic agent into the peritoneal cavity from a reservoir to form a peritoneal fluid mixture, the reservoir connected to an implantable pump by a reservoir conduit; and
pumping, using the implantable pump comprising a gear-pump and a controller, the peritoneal fluid mixture from the peritoneal cavity into the bladder responsive to control of the gear-pump by the controller, thereby treating the congestive heart failure of the subject.
12. The method of claim 11 , further comprising monitoring a physiologic parameter, and
wherein introducing the infusate comprises pumping, using the implantable pump, the infusate from the reservoir to the peritoneal cavity responsive to a value of the monitored physiologic parameter.
13. The method of claim 11 , further comprising monitoring a physiologic parameter, and
wherein pumping the peritoneal fluid mixture comprises pumping the peritoneal fluid mixture from the peritoneal cavity to the bladder responsive to a value of the monitored physiologic parameter.
14. The method of claim 11 , further comprising implanting the reservoir.
15. The method of claim 11 , wherein introducing the infusate comprises introducing the infusate into the peritoneal cavity from the reservoir through the reservoir conduit.
16. The method of claim 11 , wherein pumping the peritoneal fluid mixture comprises pumping the peritoneal fluid mixture from the peritoneal cavity through a drainage conduit into the bladder through an exit conduit,
wherein the drainage conduit is adapted for coupling between the peritoneal cavity and the implantable pump and the exit conduit is adapted for coupling between the implantable pump and the bladder.
17. The method of claim 11 , wherein introducing the infusate comprises pumping, using the implantable pump, the infusate into the peritoneal cavity from the reservoir as a function of time.
18. The method of claim 11 , wherein pumping the peritoneal fluid mixture comprises pumping the peritoneal fluid mixture from the peritoneal cavity to the bladder as a function of time.
19. The method of claim 11 , wherein pumping the peritoneal fluid mixture from the peritoneal cavity into the bladder occurs after a time-delay.
20. The method of claim 11 , wherein pumping the peritoneal fluid mixture comprises pumping the peritoneal fluid mixture at a set flow rate.